Literature DB >> 8158500

Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients.

M C Meikle1, R M Hembry, J Holley, C Horton, C G McFarlane, J J Reynolds.   

Abstract

The matrix metalloproteinases (MMPs) collagenase, gelatinase A (72 kDa gelatinase), stromelysin, and their specific inhibitor TIMP-1 (tissue inhibitor of metalloproteinases), were immunolocalized using specific polyclonal antisera in gingival tissues from 21 patients with chronic inflammatory periodontal disease. Monoclonal antibodies against macrophages (Leu-M5), B cells (Leu-14), helper T cells (OKT4), suppressor T cells (OKT8) and the HLA-DR epitope were also used to identify leukocyte subsets. MMPs were observed in connective tissues at sites that histologically showed signs of remodelling. The number and distribution of positive cells varied widely, however, not only between individual biopsy specimens, but also within the same specimen. The same was true for the composition and distribution of the inflammatory cell infiltrate. Moreover, although there was a positive correlation between the number of MMP-producing cells and the severity of inflammation in some specimens, for others with comparable leukocyte subset scoring the number was reduced and sometimes absent altogether. Cells secreting MMPs were fibroblasts, macrophages and epithelial cells. It was not possible to determine unequivocally whether a MMP-positive cell within the connective tissue was a fibroblast or a macrophage, since the antisera recognise both fibroblast and macrophage MMPs and the different fixation requirements for MMPs (4% paraformaldehyde) and Leu-M5 (acetone) precluded co-localization on the same section. TIMP-1 was immunolocalized within connective tissue cells at sites of tissue remodelling. Our results support the hypothesis that tissue-derived MMPs may be involved in tissue remodelling in periodontal disease and conclusively demonstrate that epithelial cells may be involved as well as connective tissue cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158500     DOI: 10.1111/j.1600-0765.1994.tb01100.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  6 in total

1.  Activation of neutrophil collagenase in periodontitis.

Authors:  R Romanelli; S Mancini; C Laschinger; C M Overall; J Sodek; C A McCulloch
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Excessıve fluorıde ıntake alters the MMP-2, TIMP-1 and TGF-β levels of perıodontal soft tıssues: an experımental study ın rabbıts.

Authors:  Müge Lütfioğlu; Elif Eser Sakallıoğlu; Umur Sakallıoğlu; M Yavuz Gülbahar; Mehtap Muğlalı; Burcu Baş; Abdurrahman Aksoy
Journal:  Clin Oral Investig       Date:  2011-12-07       Impact factor: 3.573

3.  Influence of phase I periodontal therapy on levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1.

Authors:  Pallavi S Ghodpage; Rajashri A Kolte; Abhay P Kolte; Madhur Gupta
Journal:  Saudi Dent J       Date:  2014-07-15

4.  Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts.

Authors:  Tove Båge; Johan Lindberg; Joakim Lundeberg; Thomas Modéer; Tülay Yucel-Lindberg
Journal:  BMC Genomics       Date:  2010-04-15       Impact factor: 3.969

5.  Dual Action of Myricetin on Porphyromonas gingivalis and the Inflammatory Response of Host Cells: A Promising Therapeutic Molecule for Periodontal Diseases.

Authors:  Daniel Grenier; Huangqin Chen; Amel Ben Lagha; Jade Fournier-Larente; Marie-Pierre Morin
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 6.  Biosensor and Lab-on-a-chip Biomarker-identifying Technologies for Oral and Periodontal Diseases.

Authors:  Larissa Steigmann; Shogo Maekawa; Corneliu Sima; Suncica Travan; Chin-Wei Wang; William V Giannobile
Journal:  Front Pharmacol       Date:  2020-11-09       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.